Published in Urology on October 01, 1997
MRI / Ultrasound Fusion With Contrast-Enhanced Ultrasound Guidance | NCT02233725
Design of a novel MRI compatible manipulator for image guided prostate interventions. IEEE Trans Biomed Eng (2005) 3.08
Imaging localized prostate cancer: current approaches and new developments. AJR Am J Roentgenol (2009) 1.89
Combined magnetic resonance imaging and magnetic resonance spectroscopy imaging in the diagnosis of prostate cancer: a systematic review and meta-analysis. Eur Urol (2008) 1.60
Geometric evaluation of systematic transrectal ultrasound guided prostate biopsy. J Urol (2012) 1.59
Individualized screening interval for prostate cancer based on prostate-specific antigen level: results of a prospective, randomized, population-based study. Arch Intern Med (2005) 1.57
CUA guidelines on prostate biopsy methodology. Can Urol Assoc J (2010) 1.44
MRI-guided prostate biopsy detects clinically significant cancer: analysis of a cohort of 100 patients after previous negative TRUS biopsy. World J Urol (2011) 1.32
Prostate MRI: diffusion-weighted imaging at 1.5T correlates better with prostatectomy Gleason Grades than TRUS-guided biopsies in peripheral zone tumours. Eur Radiol (2011) 1.29
Use of patient-specific MRI-based prostate mold for validation of multiparametric MRI in localization of prostate cancer. Urology (2012) 1.28
Comparison of sonoelastography guided biopsy with systematic biopsy: impact on prostate cancer detection. Eur Radiol (2007) 1.17
Phase 3 clinical trial investigating the effect of selenium supplementation in men at high-risk for prostate cancer. Prostate (2012) 1.15
An MRI-compatible robotic system with hybrid tracking for MRI-guided prostate intervention. IEEE Trans Biomed Eng (2011) 1.14
Positron emission tomography imaging of prostate cancer. Amino Acids (2009) 1.11
Biopsy standards for detection of prostate cancer. World J Urol (2007) 1.10
Accuracy validation for MRI-guided robotic prostate biopsy. Proc SPIE Int Soc Opt Eng (2010) 1.08
Development and Evaluation of an Actuated MRI-Compatible Robotic System for MRI-Guided Prostate Intervention. IEEE ASME Trans Mechatron (2011) 1.03
Photoacoustic tomography: a potential new tool for prostate cancer. Biomed Opt Express (2010) 1.00
Shear wave dispersion ultrasonic vibrometry for measuring prostate shear stiffness and viscosity: an in vitro pilot study. IEEE Trans Biomed Eng (2010) 1.00
Detection rate of prostate cancer on the basis of the vienna nomogram: a singapore study. Korean J Urol (2014) 1.00
A comparison of the diagnostic performance of systematic versus ultrasound-guided biopsies of prostate cancer. Eur Radiol (2006) 0.96
Biopsy needle artifact localization in MRI-guided robotic transrectal prostate intervention. IEEE Trans Biomed Eng (2012) 0.93
Design and preliminary accuracy studies of an MRI-guided transrectal prostate intervention system. Med Image Comput Comput Assist Interv (2007) 0.92
Correlated diffusion imaging. BMC Med Imaging (2013) 0.90
Beyond diagnosis: evolving prostate biopsy in the era of focal therapy. Prostate Cancer (2010) 0.89
The 20-core prostate biopsy as an initial strategy: impact on the detection of prostatic cancer. Can Urol Assoc J (2010) 0.89
Transrectal ultrasound guided biopsy of the prostate: random sextant versus biopsies of sono-morphologically suspicious lesions. World J Urol (2004) 0.88
Robotic ultrasound and needle guidance for prostate cancer management: review of the contemporary literature. Curr Opin Urol (2014) 0.88
Pain during transrectal ultrasound-guided prostate biopsy and the role of periprostatic nerve block: what radiologists should know. Korean J Radiol (2014) 0.87
Distribution of prostate carcinoma foci within the peripheral zone: analysis of 8,062 prostate biopsy cores. World J Urol (2003) 0.87
Contrast specific imaging in the detection and localization of prostate cancer. World J Urol (2004) 0.85
Three-dimensional combination of transrectal and transperineal biopsies for efficient detection of stage T1c prostate cancer. Int J Clin Oncol (2006) 0.85
New aspects in shear-wave elastography of prostate cancer. J Ultrason (2015) 0.83
Role of magnetic resonance methods in the evaluation of prostate cancer: an Indian perspective. MAGMA (2008) 0.82
Value of magnetic resonance imaging in prostate cancer diagnosis. World J Urol (2007) 0.81
Detection of prostate cancer with three-dimensional transrectal ultrasound: correlation with biopsy results. Br J Radiol (2011) 0.81
Gleason grading controversies: what the chemoprevention trials have taught us. Can Urol Assoc J (2009) 0.81
Potentials and limitations of real-time elastography for prostate cancer detection: a whole-mount step section analysis. ScientificWorldJournal (2012) 0.80
Computer aided-diagnosis of prostate cancer on multiparametric MRI: a technical review of current research. Biomed Res Int (2014) 0.80
Transrectal contrast enhanced ultrasound for diagnosis of prostate cancer. World J Urol (2007) 0.79
Urologic imaging for localized prostate cancer in 2007. World J Urol (2007) 0.79
Transrectal real-time elastography-guided transperineal prostate biopsy as an improved tool for prostate cancer diagnosis. Int J Clin Exp Med (2015) 0.78
Role of Engrailed-2 (EN2) as a prostate cancer detection biomarker in genetically high risk men. Sci Rep (2013) 0.78
Transperineal template prostate biopsies in men with raised PSA despite two previous sets of negative TRUS-guided prostate biopsies. World J Urol (2013) 0.78
Follow-up of men obtaining a six-core versus a ten-core benign prostate biopsy 7 years previously. World J Urol (2005) 0.77
A comparison of prostate cancer detection rates by 12 or 6 core biopsy at different prostate-specific antigen densities in Korean men. World J Urol (2008) 0.77
Real-time elastography of the prostate. Biomed Res Int (2014) 0.76
Imaging and intervention in prostate cancer: Current perspectives and future trends. Indian J Radiol Imaging (2014) 0.76
Tissue elasticity displayed by elastography and its correlation with the characteristics of collagen type I and type III in prostatic stroma. Asian J Androl (2014) 0.76
Three-dimensional nonrigid landmark-based magnetic resonance to transrectal ultrasound registration for image-guided prostate biopsy. J Med Imaging (Bellingham) (2015) 0.75
Non-rigid MR-TRUS image registration for image-guided prostate biopsy using correlation ratio-based mutual information. Biomed Eng Online (2017) 0.75
Trends in targeted prostate brachytherapy: from multiparametric MRI to nanomolecular radiosensitizers. Cancer Nanotechnol (2016) 0.75
MR-targeted TRUS prostate biopsy using local reference augmentation: initial experience. Int Urol Nephrol (2016) 0.75
Analysis of repeated 24-core saturation prostate biopsy: Inverse association between asymptomatic histological inflammation and prostate cancer detection. Oncol Lett (2016) 0.75
Multi-slice-to-volume registration for MRI-guided transperineal prostate biopsy. Int J Comput Assist Radiol Surg (2014) 0.75
Contemporary pathologic characteristics and oncologic outcomes of prostate cancers missed by 6- and 12-core biopsy and diagnosed with a 21-core biopsy protocol. World J Urol (2011) 0.75
When prostate cancer remains undetectable: The dilemma. Turk J Urol (2015) 0.75
The Practicality of Targeted Prostate Biopsy Procedures on the Dominant Side of the Tumor Determined by Magnetic Resonance Imaging in Elderly Patients with High Serum Levels of Prostate-Specific Antigen. World J Mens Health (2015) 0.75
Frequency of Propionibacterium acnes Infection in Prostate Glands with Negative Biopsy Results Is an Independent Risk Factor for Prostate Cancer in Patients with Increased Serum PSA Titers. PLoS One (2017) 0.75
[Innovative imaging in urology: fascination and future. Yesterday, today, and tomorrow]. Urologe A (2006) 0.75
Transrectal real-time tissue elastography targeted biopsy coupled with peak strain index improves the detection of clinically important prostate cancer. Oncol Lett (2017) 0.75
Rings of negatively charged amino acids determine the acetylcholine receptor channel conductance. Nature (1988) 6.35
What is the optimum interval between mammographic screening examinations? An analysis based on the latest results of the Swedish two-county breast cancer screening trial. Br J Cancer (1987) 6.20
Complete sequencing of the p53 gene provides prognostic information in breast cancer patients, particularly in relation to adjuvant systemic therapy and radiotherapy. Nat Med (1995) 5.85
Alcohol and breast cancer in women: a pooled analysis of cohort studies. JAMA (1998) 4.65
Update on the pathophysiology and classification of von Willebrand disease: a report of the Subcommittee on von Willebrand Factor. J Thromb Haemost (2006) 4.58
High 10-year survival rate in patients with early, untreated prostatic cancer. JAMA (1992) 4.31
The relation between survival and age at diagnosis in breast cancer. N Engl J Med (1986) 4.21
Excess mortality in bipolar and unipolar disorder in Sweden. Arch Gen Psychiatry (2001) 4.15
Adverse reactions to nitrofurantoin. Analysis of 921 reports. Am J Med (1980) 4.03
Fifteen-year survival in prostate cancer. A prospective, population-based study in Sweden. JAMA (1997) 3.80
Oscillometric twenty-four-hour ambulatory blood pressure values in healthy children and adolescents: a multicenter trial including 1141 subjects. J Pediatr (1997) 3.29
Mortality and causes of death in schizophrenia in Stockholm county, Sweden. Schizophr Res (2000) 2.88
Sector resection with or without postoperative radiotherapy for stage I breast cancer: five-year results of a randomized trial. Uppsala-Orebro Breast Cancer Study Group. J Natl Cancer Inst (1994) 2.81
Trends in prostate cancer survival in Sweden, 1960 through 1988: evidence of increasing diagnosis of nonlethal tumors. J Natl Cancer Inst (1996) 2.71
A national telepathology trial in Sweden feasibility and assessment. Arch Anat Cytol Pathol (1995) 2.68
Risk factor patterns for cryptorchidism and hypospadias. Epidemiology (1999) 2.64
10-Year results after sector resection with or without postoperative radiotherapy for stage I breast cancer: a randomized trial. J Clin Oncol (1999) 2.64
The p53 gene in breast cancer: prognostic value of complementary DNA sequencing versus immunohistochemistry. J Natl Cancer Inst (1996) 2.57
A quantitative analysis of bleeding symptoms in type 1 von Willebrand disease: results from a multicenter European study (MCMDM-1 VWD). J Thromb Haemost (2006) 2.56
Strategies for global control of cervical cancer. Int J Cancer (1995) 2.52
Disease activity and risk of lymphoma in patients with rheumatoid arthritis: nested case-control study. BMJ (1998) 2.51
Carcinoid tumors: analysis of prognostic factors and survival in 301 patients from a referral center. Ann Oncol (1997) 2.46
Increasing cancer risk in younger birth cohorts in Sweden. Lancet (1993) 2.39
Plasma insulin-like growth factor-I, insulin-like growth factor-binding proteins, and prostate cancer risk: a prospective study. J Natl Cancer Inst (2000) 2.34
Tumor associated macrophages in human prostate cancer: relation to clinicopathological variables and survival. Int J Oncol (2000) 2.28
Prognostic and predictive value of c-erbB-2 overexpression in primary breast cancer, alone and in combination with other prognostic markers. J Clin Oncol (1998) 2.09
Five-node biopsy of the axilla: an alternative to axillary dissection of levels I-II in operable breast cancer. Eur J Surg Oncol (2002) 2.09
Histopathological risk factors for ipsilateral breast events after breast conserving treatment for ductal carcinoma in situ of the breast--results from the Swedish randomised trial. Eur J Cancer (2006) 2.09
Prognostic value of immunohistochemically identifiable tumor cells in lymph nodes of patients with completely resected esophageal cancer. N Engl J Med (1997) 2.03
Significant reduction in advanced breast cancer. Results of the first seven years of mammography screening in Kopparberg, Sweden. Diagn Imaging Clin Med (1985) 2.02
Prenatal and perinatal risk factors for schizophrenia, affective psychosis, and reactive psychosis of early onset: case-control study. BMJ (1999) 1.96
[Problems of interpretation in vascular surgery]. Lakartidningen (1993) 1.94
Excessive dietary intake of vitamin A is associated with reduced bone mineral density and increased risk for hip fracture. Ann Intern Med (1998) 1.91
Fruit, vegetables, dietary fiber, and risk of colorectal cancer. J Natl Cancer Inst (2001) 1.90
Detection of preinvasive cancer of the cervix and the subsequent reduction in invasive cancer. J Natl Cancer Inst (1993) 1.87
A prospective, randomized study of cryotherapy during administration of high-dose melphalan to decrease the severity and duration of oral mucositis in patients with multiple myeloma undergoing autologous peripheral blood stem cell transplantation. Bone Marrow Transplant (2006) 1.84
Localization of the glucosyltransferase activity of Clostridium difficile toxin B to the N-terminal part of the holotoxin. J Biol Chem (1997) 1.83
Increasing survival trend after cancer diagnosis in Sweden: 1960-1984. J Natl Cancer Inst (1989) 1.82
An epidemiological study of Crohn's disease. Scand J Gastroenterol (1970) 1.81
Detailed von Willebrand factor multimer analysis in patients with von Willebrand disease in the European study, molecular and clinical markers for the diagnosis and management of type 1 von Willebrand disease (MCMDM-1VWD). J Thromb Haemost (2008) 1.81
Risk factors for uterine rupture and neonatal consequences of uterine rupture: a population-based study of successive pregnancies in Sweden. BJOG (2007) 1.80
AHF related protein in clinical praxis. Scand J Haematol (1974) 1.78
Time trends in schizophrenia mortality in Stockholm county, Sweden: cohort study. BMJ (2000) 1.77
Attenuation of sepsis-related immunoparalysis by continuous veno-venous hemofiltration in experimental porcine pancreatitis. Crit Care Med (2001) 1.74
Endometriosis and the risk of cancer with special emphasis on ovarian cancer. Hum Reprod (2006) 1.69
Survival and causes of death in patients with inflammatory bowel disease: a population-based study. Gastroenterology (1992) 1.65
Evaluation of an intensive strategy for follow-up and surveillance of primary breast cancer. Ann Surg Oncol (1998) 1.64
Rings of anionic amino acids as structural determinants of ion selectivity in the acetylcholine receptor channel. Proc Biol Sci (1991) 1.59
Mammographic screening for breast cancer. What cancers do we find? Eur J Cancer (1997) 1.58
Predictors of deterioration of lung function in cystic fibrosis. Pediatr Pulmonol (2002) 1.58
Increasing incidence of both major histological types of esophageal carcinomas among men in Sweden. Int J Cancer (1993) 1.57
No association between fat and fatty acids intake and risk of colorectal cancer. Cancer Epidemiol Biomarkers Prev (2001) 1.56
Trends in cancer of the cervix uteri in Sweden following cytological screening. Br J Cancer (1999) 1.55
Binding of platelet factor 4 to cultured human umbilical vein endothelial cells. Thromb Res (1981) 1.54
Risk factors for local recurrence after conservative treatment in stage I breast cancer. Definition of a subgroup not requiring radiotherapy. Ann Oncol (1997) 1.51
Identification of novel CHD1-associated collaborative alterations of genomic structure and functional assessment of CHD1 in prostate cancer. Oncogene (2011) 1.50
Prevention of postoperative pericardial adhesions by closure of the pericardium with absorbable polymer patches. An experimental study. J Thorac Cardiovasc Surg (1992) 1.50
Body weight and colorectal cancer risk in a cohort of Swedish women: relation varies by age and cancer site. Br J Cancer (2001) 1.49
Florence statement on breast cancer, 1998 forging the way ahead for more research on and better care in breast cancer. Eur J Cancer (1999) 1.48
Validation of International Society of Urological Pathology (ISUP) grading for prostatic adenocarcinoma in thin core biopsies using TROG 03.04 'RADAR' trial clinical data. Pathology (2015) 1.47
Increased formation of reactive oxygen species after permanent and reversible middle cerebral artery occlusion in the rat. J Cereb Blood Flow Metab (1998) 1.46
The effect of female sex hormones on cancer survival. A register-based study in patients younger than 20 years at diagnosis. JAMA (1990) 1.45
A phase I trial of DNA vaccination with a plasmid expressing prostate-specific antigen in patients with hormone-refractory prostate cancer. Br J Cancer (2004) 1.45
Screening for osteopenia and osteoporosis: selection by body composition. Osteoporos Int (1996) 1.45
Pulmonary reactions to nitrofurantoin. 447 cases reported to the Swedish Adverse Drug Reaction Committee 1966-1976. Eur J Respir Dis (1981) 1.43
Characterization of a plasma retinol-binding protein membrane receptor expressed in the retinal pigment epithelium. J Biol Chem (1992) 1.41
Risk factors for male breast cancer--a case-control study from Scandinavia. Acta Oncol (2001) 1.40
Increasing incidence of carcinoma of the gastric cardia in Sweden from 1970 to 1985. Br J Surg (1993) 1.40
Interference pattern in perineal muscles: a quantitative electromyographic study in patients before and after transurethral surgery of the prostate. Neurourol Urodyn (1997) 1.39
Arterial hypotension and hypoxaemia during total hip replacement: the importance of thromboplastic products, fat embolism and acrylic monomers. Acta Anaesthesiol Scand (1975) 1.39
A prospective study showing long-term infection with human papillomavirus 16 before the development of cervical carcinoma in situ. Cancer Res (2000) 1.38
Reasons women do not attend screening for cervical cancer: a population-based study in Sweden. Prev Med (2001) 1.38
Interference pattern in the urethral sphincter: a quantitative electromyographic study in patients before and after radical retropubic prostatectomy. Scand J Urol Nephrol (1998) 1.38
Formation and growth of multicellular spheroids of human origin. Int J Cancer (1983) 1.35
Tumour markers in breast carcinoma correlate with grade rather than with invasiveness. Br J Cancer (2001) 1.33
Purification of urokinase by affinity chromatography. Biochim Biophys Acta (1976) 1.32
Breast conservation surgery, with and without radiotherapy, in women with lymph node-negative breast cancer: a randomised clinical trial in a population with access to public mammography screening. Eur J Cancer (2003) 1.31
Two genetic variants of von Willebrand's disease. N Engl J Med (1973) 1.25
Crohn's disease. A clinical study based on 186 patients. Scand J Gastroenterol (1971) 1.25
An overview of evolution, systematics, population biology, cytogenetics, molecular biology and speciation in Ctenomys. Prog Clin Biol Res (1990) 1.25
Recurrence and progression in low grade papillary urothelial tumors. J Urol (1999) 1.25
Completeness of case ascertainment and survival time error in English cancer registries: impact on 1-year survival estimates. Br J Cancer (2011) 1.24
Risk of subsequent invasive breast cancer after breast carcinoma in situ. Lancet (2000) 1.23
Aberrant multimeric structure of von Willebrand factor in a new variant of von Willebrand's disease (type IIC). J Clin Invest (1982) 1.23
Attitudes, beliefs, and knowledge as predictors of nonattendance in a Swedish population-based mammography screening program. Prev Med (2000) 1.22
Survival in stomach cancer is improving: results of a nationwide population-based Swedish study. Ann Surg (1999) 1.22
A prospective study of association of monounsaturated fat and other types of fat with risk of breast cancer. Arch Intern Med (1998) 1.22
The risk of cancer and the role of parity among women with endometriosis. Hum Reprod (2007) 1.21
Genetic link to cervical tumours. Nature (1999) 1.20
Characterization of a platelet endoglycosidase degrading heparin-like polysaccharides. Biochemistry (1980) 1.20
Pseudoneoplastic lesions of the testis and paratesticular structures. Virchows Arch (2007) 1.19
Smoking, antioxidant vitamins, and the risk of hip fracture. J Bone Miner Res (1999) 1.19
Platelet aggregation induced by 1-desamino-8-D-arginine vasopressin (DDAVP) in Type IIB von Willebrand's disease. N Engl J Med (1983) 1.18
Alcoholism and cancer risk: a population-based cohort study. Cancer Causes Control (1992) 1.17
Immunological identity of urokinase and ovarian carcinoma plasminogen activator released in tissue culture. Nature (1976) 1.17
Significant expression of IGFBP2 in breast cancer compared with benign lesions. J Clin Pathol (2005) 1.16
Identification in vitro of an endothelial cell surface cofactor for antithrombin III. Parallel studies with isolated perfused rat hearts and microcarrier cultures of bovine endothelium. J Clin Invest (1982) 1.16